• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

KLAS Report: Providers Seek Vendors Help for Clinical Decision Support

by Fred Pennic 01/24/2013 3 Comments

According to recent KLAS Report, providers are seeking outside vendors help for clinical decision support as they struggle to embed that content into their EMR and clinical workflows.

Although providers are able to leverage clinical evidence from third-party clinical decision support vendors, improvements with EMR and workflow integration are still needed, according to a new report from KLAS — Clinical Decision Support 2012: Order Sets, Care Plans, Drug Databases. The research addresses the challenges that providers have to stay current with a growing body of clinical evidence and then using it to affect decisions at the point of care.

”The focus of this report is what vendors are doing to address the challenges that providers have to stay current with a growing body of clinical evidence and then using it to affect decisions at the point of care,” says report author Coray Tate. “Order sets, care plans, and drug databases clearly play important roles in what healthcare reform is trying to accomplish. Realizing their benefit requires coordinated efforts from CDS and EMR vendors and, most importantly, determination on the part of providers.”

The study looks at how the three separate types of CDS tools interact with providers’ EMRs. It compares third-party vendors’ performance as well as the contributions of the different EMR solutions. Care plan and order set vendors include Elsevier, Wolters Kluwer, and Zynx Health. Drug database vendors include Cerner Multum, First Databank, and Wolters Kluwer Medi-Span.

Key topics of the report include:

  • Movement toward third-party solutions
  • Order Set integration challenges decrease overall value
  • Providers need more control over alerts
  • EMR vendors need to be part of the solution

For more detailed information on each vendor’s performance and the KLAS report Clinical Decision Support 2012: Order Sets, Care Plans, Drug Databases, visit KLAS online at www.KLASresearch.com/reports.

 

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Q/A: Oatmeal Health Co-Founder Talks AI-Enabled Cancer Screening for the Underserved

Q/A: Oatmeal Health Co-Founder Talks AI-Enabled Cancer Screening for the Underserved

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |